Skip to main content

Table 1 Expression of cancers in carriers of PMS2 c.989-1G > T

From: The Norwegian PMS2 founder mutation c.989-1G > T shows high penetrance of microsatellite instable cancers with normal immunohistochemistry

Cancer

All (n = 22)

Women (n = 13)

Men (n = 9)

Colorectum

12 (54.5%)

6 (46.2%)

6 (66.7%)

Stomach

3 (13.6%)

-

3 (33.3%)

Kidney

1 (4.5%)

1 (7.7%)

-

Malignant melanoma

1 (4.5%)

1 (7.7%)

-

Sarcoma

1 (4.5%)

1 (7.7%)

-

Endometrium

-

5 (38.5%)

-

Ovary

-

1 (7.7%)

-

Breast

-

3 (23.1%)

-

Prostate

-

-

2 (22.2%)